CLOSE

Subscribe to email alerts

MediPharm Labs 03/06/2020

MediPharm Labs Announces Participation at Upcoming Conferences

BARRIE, Ontario, May 29, 2020 (GLOBE NEWSWIRE)

MediPharm Labs Corp., (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, is pleased to announce its participation at upcoming virtual investor conferences.

  • Monday, June 1, 2020: Benzinga Cannabis Capital Conference
  • Wednesday, June 3, 2020: Jefferies Global Healthcare Conference

A link to the live audio webcast will be available prior to the start of the event and can be accessed through the events section of MediPharm Labs Investor Relations website at https://ir.medipharmlabs.com/ir-calendar. An archived webcast will also be made available after the event.

 Please see the presentation slides here.

Back to News

Related Articles

MediPharm Labs

MediPharm Labs Reports Q4 2018

07/05/2019 Read more
MediPharm Labs

MediPharm Labs Reports Q1 2019

13/05/2019 Read more
MediPharm Labs

MediPharm Labs Australia Awarded Cannabis Manufacturing Licence

23/05/2019 Read more
MediPharm Labs

MediPharm Labs Receives Permits and Ships First Medical Cannabis Concentrate to Australia

25/06/2019 Read more

CLOSE

Subscribe to email alerts